Geron (GERN) Receivables - Other (2010 - 2026)
Geron's (GERN) quarterly Receivables - Other came in at $1.9 million in Q2 2026, down 32.38% year-over-year from $2.8 million in Q2 2025, and down 15.82% quarter-over-quarter from $2.2 million in Q1 2026.
Analysis
Geron (GERN) Receivables - Other (2010 - 2026) Analysis & Trends
Geron has disclosed Receivables - Other across 17 years of filings, most recently posting $1.9 million for Q2 2026.
- In Q2 2026, Receivables - Other fell 32.38% year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.9 million (down 32.38% YoY), while the FY2025 annual figure was $2.2 million, down 21.52% from the prior year.
- Receivables - Other came in at $1.9 million for Q2 2026 at Geron, down from $2.2 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $22.2 million in Q3 2022 to a low of $1.6 million in Q1 2024.
- Average Receivables - Other over 5 years is $5.0 million, with a median of $2.8 million recorded in 2025.
- Year-over-year, Receivables - Other soared 3543.11% in 2022 and tumbled 85.89% in 2024.
- Over 5 years, Receivables - Other stood at $3.1 million in 2022, then plunged by 47.36% to $1.7 million in 2023, then soared by 72.39% to $2.9 million in 2024, then slipped by 21.52% to $2.2 million in 2025, then dropped by 16.79% to $1.9 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $1.9 million in Q2 2026, $2.2 million in Q1 2026, and $2.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 2.21 Mn |
| Dec 31, 2025 | 2.24 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 2.76 Mn |
| Mar 31, 2025 | 2.82 Mn |
| Dec 31, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 14.75 Mn |
| Jun 30, 2023 | 7.00 Mn |
| Mar 31, 2023 | 8.35 Mn |
| Dec 31, 2022 | 3.14 Mn |
| Sep 30, 2022 | 22.22 Mn |
| Jun 30, 2022 | 4.25 Mn |
| Mar 31, 2022 | 5.24 Mn |
| Dec 31, 2021 | 1.76 Mn |
| Sep 30, 2021 | 610,000.00 |